Grants per year
Personal profile
Education/Academic qualification
PhD, Ohio State University
… → 2011
Fingerprint
Dive into the research topics where Dan Xu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 10 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Grants
-
A novel therapy for scleroderma using biodegradable nanoparticles
Miller, S. D., Varga, J. & Xu, D.
9/1/18 → 8/31/21
Project: Research project
-
Innate and Adaptive Immunity in Epileptogenesis of Childhood Epilepsy
Epilepsy Foundation of America
2/1/13 → 1/31/14
Project: Research project
-
Innate and Adaptive Immunity in Epileptogenesis
Ann & Robert H. Lurie Children's Hospital of Chicago, National Institute of Neurological Disorders and Stroke
7/15/11 → 8/31/15
Project: Research project
Research Output
-
Intravenous Immunomodulatory Nanoparticle Treatment for Traumatic Brain Injury
Sharma, S., Ifergan, I., Kurz, J. E., Linsenmeier, R. A., Xu, D., Cooper, J. G., Miller, S. D. & Kessler, J. A., Mar 1 2020, In: Annals of neurology. 87, 3, p. 442-455 14 p.Research output: Contribution to journal › Article › peer-review
6 Scopus citations -
Peripherally derived T regulatory and γδ T cells have opposing roles in the pathogenesis of intractable pediatric epilepsy
Xu, D., Robinson, A. P., Ishii, T., Duncan, DA. S., Alden, T. D., Goings, G. E., Ifergan, I., Podojil, J. R., Penaloza-MacMaster, P., Kearney, J. A., Swanson, G. T., Miller, S. D. & Koh, S., Apr 1 2018, In: Journal of Experimental Medicine. 215, 4, p. 1169-1186 18 p.Research output: Contribution to journal › Article › peer-review
18 Scopus citations -
Tolerogenic Ag-PLG nanoparticles induce tregs to suppress activated diabetogenic CD4 and CD8 T cells
Prasad, S., Neef, T., Xu, D., Podojil, J. R., Getts, D. R., Shea, L. D. & Miller, S. D., May 2018, In: Journal of Autoimmunity. 89, p. 112-124 13 p.Research output: Contribution to journal › Article › peer-review
24 Scopus citations -
Intravenous immune-modifying nanoparticles as a therapy for spinal cord injury in mice
Jeong, S. J., Cooper, J. G., Ifergan, I., McGuire, T. L., Xu, D., Hunter, Z., Sharma, S., McCarthy, D., Miller, S. D. & Kessler, J. A., Dec 2017, In: Neurobiology of Disease. 108, p. 73-82 10 p.Research output: Contribution to journal › Article › peer-review
24 Scopus citations -
Targeting the GM-CSF receptor for the treatment of CNS autoimmunity
Ifergan, I., Davidson, T. S., Kebir, H., Xu, D., Palacios-Macapagal, D., Cann, J., Rodgers, J. M., Hunter, Z. N., Pittet, C. L., Beddow, S., Jones, C. A., Prat, A., Sleeman, M. A. & Miller, S. D., Nov 2017, In: Journal of Autoimmunity. 84, p. 1-11 11 p.Research output: Contribution to journal › Article › peer-review
25 Scopus citations